Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels
about
Emerging targets in lipid-based therapyExperimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Pathogenesis of Systemic Sclerosis.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosisRegulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformationThe emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Description of the sphingolipid content and subspecies in the diabetic corneaUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Sphingolipid regulation of tissue fibrosisA modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosisInteractions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease.Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
P2860
Q28655456-3449951F-CCF7-44A0-A58D-AD0B2367573CQ34995163-092D259C-ECE5-4B43-B21A-EAE84BBA62B5Q35693212-CB3950F0-1423-47CA-A3AA-B06163BB7906Q35954579-B78683AC-42C0-43CE-8FCB-27DC93EAA9EDQ36093802-6410198E-4EDA-4FE9-85F0-6E78D4110188Q36174374-E2438EC7-5A90-4471-86DE-CE495AD36C58Q36587156-D2FFC044-9485-4510-878B-CC9D362831D1Q36608066-462C5AA2-9536-4374-B472-010C3E65706CQ37638268-310D0501-0AF1-4532-8A5C-7376C91AC493Q38026843-CFA91D28-60CC-40F7-8378-385346CBD39BQ40047502-BBD927F1-4DFD-46D6-8343-7DB66EB8286AQ42652598-D99A7B42-A813-40F8-9791-DEF15847689AQ47109594-00A25B67-7299-4DB2-BADA-7F2E47C7E7EFQ47273613-7E48D679-49B1-4328-B5AB-91EE6DE18CADQ57491837-72413C6F-6B05-4818-911E-ED9A107FC78D
P2860
Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@ast
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@en
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@nl
type
label
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@ast
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@en
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@nl
prefLabel
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@ast
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@en
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@nl
P2093
P2860
P356
P1476
Dihydrosphingosine 1-phosphate ...... tase and tensin homolog levels
@en
P2093
Andreea Bujor
Kristin Highland
Maria Trojanowska
Shizhong Bu
Yoshihide Asano
P2860
P304
P356
10.1002/ART.27463
P577
2010-07-01T00:00:00Z